Sleep disturbances associated with attention deficit hyperactivity disorder: The impact of psychiatric comorbidity and pharmacotherapy

被引:106
|
作者
Mick, E
Biederman, J
Jetton, J
Faraone, SV
机构
[1] Massachusetts Gen Hosp, Pediat Psychopharmacol Unit, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
[3] Harvard Inst Psychiat Epidemiol & Genet, Boston, MA USA
[4] Harvard Univ, Sch Med, Brockton W Roxbury Vet Affairs Med Ctr, Boston, MA USA
[5] Massachusetts Hlth Ctr, Boston, MA USA
关键词
D O I
10.1089/10445460050167331
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: To estimate the relative risk of sleep problems associated with attention deficit hyperactivity disorder (ADHD), its pharmacotherapy, and its comorbid psychopathology, Method: Standard sleep questionnaires were used to assess sleep problems and characteristics in ADHD (n = 122) and non-ADHD (n = 105) comparison youths. Results: ADHD was associated with 10 of 19 sleep problems assessed. However, after controlling for psychiatric comorbidity and pharmacotherapy with stimulants, the majority of these differences were no longer evident, Rather, treatment with stimulants and comorbidity with anxiety and behavior disorders were significantly associated with sleep disturbances. Positive family history of ADHD was associated with none of the sleep problems assessed here after adjusting for age, psychiatric comorbidity, and treatment with anti-ADHD medication, Conclusions: Although subjective sleep difficulties are common in ADHD youths, they are frequently accounted for by comorbidity and pharmacotherapy, Furthermore, the lack of an association between a positive family history of ADHD and sleep difficulties suggests that ADHD is not a misdiagnosis of the consequences of disruption of normal sleep.
引用
收藏
页码:223 / 231
页数:9
相关论文
共 50 条
  • [31] Pharmacotherapy of attention deficit hyperactivity disorder in adults
    Wilens, TE
    Biederman, J
    Spencer, TJ
    CNS DRUGS, 1998, 9 (05) : 347 - 356
  • [32] CURRENT PHARMACOTHERAPY OF ATTENTION DEFICIT HYPERACTIVITY DISORDER
    Reddy, D. S.
    DRUGS OF TODAY, 2013, 49 (10) : 647 - 665
  • [33] Pharmacotherapy of attention deficit hyperactivity disorder in adults
    Retz, W.
    Retz-Junginger, P.
    Davydenko, S.
    Roesler, M.
    NERVENARZT, 2020, 91 (07): : 583 - 590
  • [34] Pharmacotherapy of attention deficit hyperactivity disorder in adults
    Adam, C
    Döpfner, M
    Lehmkuhl, G
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1999, 67 (08) : 359 - 366
  • [35] Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Adults
    Timothy E. Wilens
    Joseph Biederman
    Thomas J. Spencer
    CNS Drugs, 1998, 9 : 347 - 356
  • [36] Sleep disturbances in adolescents with symptoms of attention-deficit/hyperactivity disorder
    Stein, D
    Pat-Horenczyk, R
    Blank, S
    Dagan, Y
    Barak, Y
    Gumpel, TP
    JOURNAL OF LEARNING DISABILITIES, 2002, 35 (03) : 268 - 275
  • [37] Sleep Disturbances in Singaporean Children with Attention Deficit Hyperactivity Disorder Reply
    Lim, Choon Guan
    Fung, Daniel S. S.
    Ooi, Yoon Phaik
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2009, 38 (07) : 648 - 648
  • [38] Sleep disturbances in 50 children with attention-deficit hyperactivity disorder
    Hora das Neves, Sergio Nolasco
    Reimao, Rubens
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2A) : 228 - 233
  • [39] Attention Deficit Hyperactivity Disorder and Sleep Disturbances: Consideration of Parental Influence
    Noble, Gretchen Stuckert
    O'Laughlin, Liz
    Brubaker, Brad
    BEHAVIORAL SLEEP MEDICINE, 2012, 10 (01) : 41 - 53
  • [40] Assessment of Sleep disturbances in children with Attention-deficit hyperactivity disorder
    Hazari, Nandita
    Joseph, Angela
    Mehta, Manju
    Sagar, Rajesh
    JOURNAL OF INDIAN ASSOCIATION FOR CHILD AND ADOLESCENT MENTAL HEALTH, 2015, 11 (01): : 56 - 79